Novel neisseria meningitidis compounds and anti-infection applications thereof

Details for Australian Patent Application No. 2006200691 (hide)

Owner Institut National de la Sante et de la Recherche Medicale (INSERM) MaxPlanck-Gessellschaft zur Forderung des Wissenschaften e.v.

Inventors Merker, Petra; Tinsley, Colin; Achtmanb, Mark; Klee, Silke; Nassif, Xavier

Agent Watermark

Pub. Number AU-A-2006200691

Parent 68254

Filing date 20 February 2006

Wipo publication date 23 March 2006

International Classifications

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

Event Publications

9 March 2006 Complete Application Filed

23 March 2006 Application Open to Public Inspection

  Published as AU-A-2006200691

15 November 2007 Assignment before Grant

  Max-Planck-Gessellschaft zur Forderung des Wissenscaften e.V.; Institut National de la Sante et de la Recherche Medicale (INSERM) The application has been assigned to Institut National de la Sante et de la Recherche Medicale (INSERM)

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200692-AlMgMn Alloy Product for Welded Construction with Improved Corrosion Resistance

2006200690-Edible pet chew